BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1381423)

  • 1. Cellular localisation of c-myc product in human colorectal epithelial neoplasia.
    Royds JA; Sharrard RM; Wagner B; Polacarz SV
    J Pathol; 1992 Mar; 166(3):225-33. PubMed ID: 1381423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical expression of fatty acid synthase, apoptotic-regulating genes, proliferating factors, and ras protein product in colorectal adenomas, carcinomas, and adjacent nonneoplastic mucosa.
    Visca P; Alò PL; Del Nonno F; Botti C; Trombetta G; Marandino F; Filippi S; Di Tondo U; Donnorso RP
    Clin Cancer Res; 1999 Dec; 5(12):4111-8. PubMed ID: 10632348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression and significance of APC, beta-catenin, C-myc, and Cyclin D1 proteins in colorectal carcinoma].
    Dai WB; Ren ZP; Chen WL; DU J; Shi Z; Tang DY
    Ai Zheng; 2007 Sep; 26(9):963-6. PubMed ID: 17927853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-myc protein distribution. Neoplastic tissues of the human colon.
    Tulchin N; Ornstein L; Harpaz N; Guillem J; Borner C; O'Toole K
    Am J Pathol; 1992 Mar; 140(3):719-29. PubMed ID: 1372161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of cells expressing myc proteins in human colorectal epithelium, polyps, and malignant tumors.
    Melhem MF; Meisler AI; Finley GG; Bryce WH; Jones MO; Tribby II; Pipas JM; Koski RA
    Cancer Res; 1992 Nov; 52(21):5853-64. PubMed ID: 1394214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical demonstration of altered intracellular localization of the C-Myc oncogene product in human colorectal neoplasms.
    Williams AR; Piris J; Wyllie AH
    J Pathol; 1990 Apr; 160(4):287-93. PubMed ID: 2193134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of the AP-1 transcription factor family members in human colorectal epithelial and neuroendocrine neoplasms.
    Zhang W; Hart J; McLeod HL; Wang HL
    Am J Clin Pathol; 2005 Jul; 124(1):11-9. PubMed ID: 15923159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early expression of bcl-2 protein in the adenoma-carcinoma sequence of colorectal neoplasia.
    Kaklamanis L; Savage A; Mortensen N; Tsiotos P; Doussis-Anagnostopoulou I; Biddolph S; Whitehouse R; Harris AL; Gatter KC
    J Pathol; 1996 May; 179(1):10-4. PubMed ID: 8691332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between EBV infection and expression of cellular proteins c-Myc, Bcl-2, and Bax in gastric carcinomas.
    Lima MA; Ferreira MV; Barros MA; Pardini MI; Ferrasi AC; Mota RM; Rabenhorst SH
    Diagn Mol Pathol; 2008 Jun; 17(2):82-9. PubMed ID: 18382371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization and expression of p27KIP1 in multistage colorectal carcinogenesis.
    Ciaparrone M; Yamamoto H; Yao Y; Sgambato A; Cattoretti G; Tomita N; Monden T; Rotterdam H; Weinstein IB
    Cancer Res; 1998 Jan; 58(1):114-22. PubMed ID: 9426067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical detection of ras p21 and c-myc p62 in colonic adenomas and carcinomas.
    Agnantis NJ; Apostolikas N; Sficas C; Zolota V; Spandidos DA
    Hepatogastroenterology; 1991 Jun; 38(3):239-42. PubMed ID: 1937363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferation and apoptosis in proliferative lesions of the colon and rectum.
    Kikuchi Y; Dinjens WN; Bosman FT
    Virchows Arch; 1997 Aug; 431(2):111-7. PubMed ID: 9293892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas.
    Krajewska M; Moss SF; Krajewski S; Song K; Holt PR; Reed JC
    Cancer Res; 1996 May; 56(10):2422-7. PubMed ID: 8625322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma.
    Kataoka H; Hamasuna R; Itoh H; Kitamura N; Koono M
    Cancer Res; 2000 Nov; 60(21):6148-59. PubMed ID: 11085539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of the chromosome 11 mucin genes in colorectal cancer.
    Sylvester PA; Myerscough N; Warren BF; Carlstedt I; Corfield AP; Durdey P; Thomas MG
    J Pathol; 2001 Oct; 195(3):327-35. PubMed ID: 11673830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of the 67-kD laminin receptor correlates with tumour progression in human colorectal carcinoma.
    Sanjuán X; Fernández PL; Miquel R; Muñoz J; Castronovo V; Ménard S; Palacín A; Cardesa A; Campo E
    J Pathol; 1996 Aug; 179(4):376-80. PubMed ID: 8869283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis in colorectal carcinoma occurring in patients aged 45 years and under: relationship to prognosis, mitosis, and immunohistochemical demonstration of p53, c-myc and bcl-2 protein products.
    Langlois NE; Lamb J; Eremin O; Heys SD
    J Pathol; 1997 Aug; 182(4):392-7. PubMed ID: 9306959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High c-myc protein expression in benign colorectal lesions correlates with the degree of dysplasia.
    Pavelic ZP; Pavelic L; Kuvelkar R; Gapany SR
    Anticancer Res; 1992; 12(1):171-5. PubMed ID: 1567165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of human selenium-binding protein 1 is a late event in colorectal carcinogenesis and is associated with poor survival.
    Kim H; Kang HJ; You KT; Kim SH; Lee KY; Kim TI; Kim C; Song SY; Kim HJ; Lee C; Kim H
    Proteomics; 2006 Jun; 6(11):3466-76. PubMed ID: 16645984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.